Stock Information
Janux Therapeutics Inc (JANX)
Ticker Symbol: JANX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $892.59 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.8334
Revenue (TTM): $0.16 M
Dividend Yield: N/A%
ROE: -11.55%
Latest News
-
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014
Thu, Apr 16, 2026 4:02 PM
-
UBS Downgrades Janux Therapeutics to Neutral, Lowers Price Target to $15
Wed, Apr 15, 2026 2:06 PM
Key Financials
Financial data not available